- MarketWatch•last month
European stocks gain Friday, with drugmaker shares showing strength, as the Stoxx Europe 600 notches its highest close of the year.
- Bloomberg•last month
Lonza Group AG agreed to buy U.S. capsule maker Capsugel SA from KKR & Co. for $5.5 billion, as the Swiss biotech and specialty chemicals company seeks to focus more on health care.
- Bloomberg•5 months ago
Lonza Group AG agreed to buy InterHealth Nutraceuticals for as much as $300 million, a sign the Swiss chemical maker may be back on the hunt for major acquisitions after a break of almost five years.
LONN.VX : Summary for LONZA N - Yahoo Finance
LONZA N (LONN.VX)
Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
|Bid||182.00 x 60500|
|Ask||185.20 x 66200|
|Day's Range||181.30 - 185.00|
|52 Week Range||133.50 - 189.60|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|